M Fong

Medicine · Health Sciences

10h-index1.7kcitations15works0.52yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cytokine Signaling Pathways and Interactions(3), Vitamin D Research Studies(2), Nutrition and Health in Aging(2), Cancer, Hypoxia, and Metabolism(2), Inflammatory mediators and NSAID effects(2)

Publications15 total

A pilot study of pembrolizumab and peptide receptor radionuclide therapy for patients with well-differentiated neuroendocrine tumors and symptomatic and/or progressive metastases
Endocrine Abstracts·2025· 1 cited
EASY AND EFFICIENT LENTIVIRAL TRANSDUCTION WITH A MACROPOROUS TRANSDUCTION SPONGE
Cytotherapy·2024
A pilot study of pembrolizumab and peptide receptor radionuclide therapy for patients with metastatic well-differentiated neuroendocrine tumors
Endocrine Abstracts·2023· 1 cited
Species dependent differences in the actions of sympathetic nerves and noradrenaline in the internal anal sphincter
Neurogastroenterology & Motility·2007· 39 cited
Fluid Deficits and Hypotension during Colonoscopy
Anaesthesia and Intensive Care·2006· 1 citedOpen Access
ChemInform Abstract: Novel Inhibitors of Cell Adhesion Molecule Expression.
ChemInform·1997
Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-α and IL-6 release by endotoxin-stimulated macrophages
The Journal of Immunology·1995· 159 cited
Potential involvement of IL-10 in suppressing tumor-associated macrophages. Colon-26-derived prostaglandin E2 inhibits TNF- <i>alpha</i> release via a mechanism involving IL-10.
The Journal of Immunology·1995· 129 citedOpen Access
Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2.
The Journal of Experimental Medicine·1994· 367 cited
Inhibition of lipopolysaccharide and IL-1 but not of TNF-induced activation of human endothelial cells by suramin.
The Journal of Immunology·1994· 10 cited
Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo.
Journal of Clinical Investigation·1993· 132 citedOpen Access
Mechanisms of experimental cancer cachexia. Local involvement of IL-1 in colon-26 tumor
The Journal of Immunology·1993· 113 cited
Mechanisms of experimental cancer cachexia. Interaction between mononuclear phagocytes and colon-26 carcinoma and its relevance to IL-6-mediated cancer cachexia
The Journal of Immunology·1992· 111 citedOpen Access
Evidence for the involvement of interleukin 6 in experimental cancer cachexia.
Journal of Clinical Investigation·1992· 650 citedOpen Access
Regulation of murine mononuclear phagocyte inflammatory products by macrophage colony-stimulating factor. Lack of IL-1 and prostaglandin E2 production and generation of a specific IL-1 inhibitor
The Journal of Immunology·1991· 23 citedOpen Access

Frequent Co-authors

Gideon Strassmann(9), Chaim O. Jacob(3), Taku Kambayashi(3), Norma L. Graber(2), MD David Y. Oh(2), MD Emily K. Bergsland(2), MD Thomas A. Hope(2), J S Kenney(1), Vina Patil-koota(1), F D Finkelman(1), Dandan Zhou(1), N. Mazurek(1), Carl E. Freter(1), S Windsor(1), F D'Alessandro(1), Richard P. Nordan(1), H. Richard Alexander(1), Yoshihiro Masui(1), R Chizzonite(1), Rick L. Evans(1)